Loading...

We've got a brand new version of Simply Wall St! Try it out

Flower One Holdings

CNSX:FONE
Snowflake Description

Limited growth with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FONE
CNSX
CA$341M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. The last earnings update was 38 days ago. More info.


Add to Portfolio Compare Print
  • Flower One Holdings has significant price volatility in the past 3 months.
FONE Share Price and Events
7 Day Returns
-1.1%
CNSX:FONE
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-
CNSX:FONE
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
FONE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Flower One Holdings (FONE) -1.1% -20.7% -33.3% - - -
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • No trading data on FONE.
  • No trading data on FONE.
Price Volatility
Industry
5yr Volatility vs Market

FONE Value

 Is Flower One Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Flower One Holdings. This is due to cash flow or dividend data being unavailable. The share price is CA$1.88.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Flower One Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Flower One Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:FONE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $0.06
CNSX:FONE Share Price ** CNSX (2019-09-19) in CAD CA$1.88
CNSX:FONE Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $1.42
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Flower One Holdings.

CNSX:FONE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:FONE Share Price ÷ EPS (both in USD)

= 1.42 ÷ 0.06

24.64x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Flower One Holdings is overvalued based on earnings compared to the CA Pharmaceuticals industry average.
  • Flower One Holdings is overvalued based on earnings compared to the Canada market.
Price based on expected Growth
Does Flower One Holdings's expected growth come at a high price?
Raw Data
CNSX:FONE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 24.64x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Flower One Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Flower One Holdings's assets?
Raw Data
CNSX:FONE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $0.54
CNSX:FONE Share Price * CNSX (2019-09-19) in CAD CA$1.88
CNSX:FONE Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $1.42
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:FONE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:FONE Share Price ÷ Book Value per Share (both in USD)

= 1.42 ÷ 0.54

2.62x

* Primary Listing of Flower One Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Flower One Holdings is overvalued based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Flower One Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Flower One Holdings has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FONE Future Performance

 How is Flower One Holdings expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
98%
Expected annual growth in revenue.
Earnings growth vs Low Risk Savings
Is Flower One Holdings expected to grow at an attractive rate?
  • Unable to compare Flower One Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Flower One Holdings's earnings growth to the Canada market average as no estimate data is available.
  • Flower One Holdings's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
CNSX:FONE Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:FONE Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 98%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:FONE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:FONE Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 192 58 2
2020-12-31 161 38 51 3
2019-12-31 9 -27 2
2019-09-20
CNSX:FONE Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 1 -17 10
2019-03-31 1 -12 -10
2018-12-31 0 -5 -12

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Flower One Holdings is high growth as no earnings estimate data is available.
  • Flower One Holdings's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:FONE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Flower One Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:FONE Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31
2019-09-20
CNSX:FONE Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 0.06
2019-03-31 -0.06
2018-12-31 -0.09

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Flower One Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Flower One Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Flower One Holdings has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FONE Past Performance

  How has Flower One Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Flower One Holdings's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Unable to establish if Flower One Holdings's year on year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
  • Unable to compare Flower One Holdings's 1-year earnings growth to the 5-year average as it has been trading publicly for less than 3 years.
  • Flower One Holdings has been loss making too recently or no data is available, we can't compare it to the CA Pharmaceuticals industry average.
Earnings and Revenue History
Flower One Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Flower One Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:FONE Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 1.30 9.86 15.79
2019-03-31 0.67 -10.31 12.51
2018-12-31 0.13 -12.45 8.29

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Flower One Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Flower One Holdings used its assets less efficiently than the CA Pharmaceuticals industry average last year based on Return on Assets.
  • Unable to establish if Flower One Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.
X
Past performance checks
We assess Flower One Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Flower One Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FONE Health

 How is Flower One Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Flower One Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Flower One Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Flower One Holdings's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Flower One Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Flower One Holdings Company Filings, last reported 2 months ago.

CNSX:FONE Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 97.89 44.91 0.60
2019-03-31 71.61 33.66 5.72
2018-12-31 68.58 32.08 2.59
  • Flower One Holdings's level of debt (45.9%) compared to net worth is high (greater than 40%).
  • Unable to establish if Flower One Holdings's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 7.3x coverage).
X
Financial health checks
We assess Flower One Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Flower One Holdings has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FONE Dividends

 What is Flower One Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Flower One Holdings dividends.
If you bought CA$2,000 of Flower One Holdings shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Flower One Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Flower One Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:FONE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:FONE Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31
2020-12-31
2019-12-31
2019-09-20

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Flower One Holdings has not reported any payouts.
  • Unable to verify if Flower One Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Flower One Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Flower One Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Flower One Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Flower One Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Flower One Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FONE Management

 What is the CEO of Flower One Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Ken Villazor
AGE 50
TENURE AS CEO 1.7 years
CEO Bio

Mr. Ken Villazor serves as President, Chief Executive Officer and Director of Flower One Holdings Inc January 2018. Mr. Villazor serves as an Independent Director at Organic Garage Ltd. since 2016. He has worked for Senators Sports & Entertainment since August 2003 serving principally as an Adviser to the Owner, Chairman and Chief Executive Officer of the National Hockey League's Ottawa Senators. Mr. Villazor has more than 20 years of experience in Corporate Affairs including communications, public relations, business development, regulatory affairs, government relations, philanthropy and public policy. He has held numerous senior positions in the pharmaceutical industry working extensively in government regulated aspects of commercial operations including formulary/market access, pricing compliance, price controls, manufacturing grants, regulatory approvals and shaping federal and provincial government policies. He has worked for a number of large pharmaceutical companies including SmithKline Beecham, GlaxoSmithKline and Biovail Corporation as well as with the industry’s national trade association based in Ottawa. In addition, Mr. Villazor also spent more than decade in the sports and entertainment industry including having served as an Alternate Governor to a National Hockey League franchise. Mr. Villazor is also a member of the development group selected as the highest ranked proponent by the National Capital Commission to redevelop the 53 acre LeBreton Flats site in downtown Ottawa. Mr. Villazor sits on the Board of Directors of the Ottawa Senators Foundation. His board experience spans the academic sector, not-for-profit sector and publicly-traded companies. Mr. Villazor holds a Bachelor of Science (Hon) degree from St. Michael's College at the University of Toronto.

CEO Compensation
  • Insufficient data for Ken to compare compensation growth.
  • Insufficient data for Ken to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the Flower One Holdings management team in years:

1.3
Average Tenure
41
Average Age
  • The average tenure for the Flower One Holdings management team is less than 2 years, this suggests a new team.
Management Team

Ken Villazor

TITLE
President
AGE
50
TENURE
1.7 yrs

Geoff Miachika

TITLE
Chief Financial Officer
AGE
37
TENURE
1.3 yrs

Debbie Bingham

TITLE
Director of Sales & Marketing

Kellen O'Keefe

TITLE
Chief Strategy Officer
AGE
37
TENURE
0.2 yrs

Jean Martin

TITLE
Corporate Secretary
AGE
45
Board of Directors Tenure

Average tenure and age of the Flower One Holdings board of directors in years:

1.5
Average Tenure
48
Average Age
  • The average tenure for the Flower One Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ken Villazor

TITLE
President
AGE
50
TENURE
1.7 yrs

Amit Varma

TITLE
Non-Executive Director
AGE
36
TENURE
1.5 yrs

Warner Fong

TITLE
Non Executive Director
AGE
53
TENURE
1.5 yrs

David Wesley

TITLE
Non-Executive Director
AGE
46
TENURE
1.5 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
26. Oct 18 Buy Andrew Jackson Individual 26. Oct 18 26. Oct 18 10,000 CA$1.55 CA$15,500
26. Oct 18 Buy David Wesley Individual 23. Oct 18 26. Oct 18 122,500 CA$1.59 CA$187,213
26. Oct 18 Buy Warner Fong Individual 26. Oct 18 26. Oct 18 8,000 CA$1.60 CA$12,768
17. Oct 18 Buy Warner Fong Individual 12. Oct 18 17. Oct 18 30,000 CA$1.53 CA$41,930
19. Oct 18 Buy Karl Fox Individual 10. Oct 18 10. Oct 18 125,000 CA$1.71 CA$202,361
18. Oct 18 Buy Geoffrey Miachika Individual 18. Oct 18 18. Oct 18 2,200 CA$1.38 CA$3,036
18. Oct 18 Buy Amit Varma Individual 12. Oct 18 16. Oct 18 165,367 CA$1.61 CA$264,290
15. Oct 18 Buy Geoffrey Miachika Individual 11. Oct 18 11. Oct 18 2,800 CA$1.60 CA$4,480
X
Management checks
We assess Flower One Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Flower One Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FONE News

Simply Wall St News

FONE Company Info

Description

Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada. It owns and operates a 25,000 square foot indoor cultivation and production facility in North Las Vegas with 9 grow rooms; and 455,000 square-foot greenhouse and production facility in Nevada. The company offers NLV Organics consumer brand of cannabis products; and cultivates, processes, produces, and packages dry flower, pre-rolls, cannabis oils, distillates, concentrates, edibles, topicals, and infused products. It also focuses on the resale and wholesale of cannabis products and provision of contract cultivation, production, and packaging consumer cannabis brands. The company headquartered in Toronto, Canada.

Details
Name: Flower One Holdings Inc.
FONE
Exchange: CNSX
Founded:
CA$341,209,703
181,494,523
Website: http://www.flowerone.com
Address: Flower One Holdings Inc.
20 Richmond Street West,
Suite 600,
Toronto,
Ontario, M5C 2R9,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX FONE Common Shares Canadian National Stock Exchange CA CAD 10. Oct 2018
OTCPK FLOO.F Common Shares Pink Sheets LLC US USD 10. Oct 2018
Number of employees
Current staff
Staff numbers
38
Flower One Holdings employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 01:31
End of day share price update: 2019/09/19 00:00
Last estimates confirmation: 2019/09/16
Last earnings filing: 2019/08/13
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.